Phase Advance Is an Actimetric Correlate of Antidepressant Response to Sleep Deprivation and Light Therapy in Bipolar Depression
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The combination of total sleep deprivation (TSD) and light therapy (LT) in bipolar depression causes rapid antidepressant effects, and its mechanism of action has been hypothesized to involve the enhancement of all of the monoaminergic systems targeted by antidepressant drugs (serotonin, dopamine, norepinephrine). It is still unknown if the clinical effects are paralleled by changes in biological rhythms. In a before/after design of a study of biological correlates of response, 39 inpatients affected by Type I Bipolar Disorder whose current depressive episode was without psychotic features were treated for one week with repeated TSD combined with morning LT. Wrist actigraphy was recorded throughout the study. Two-thirds of the patients responded to treatment (50% reduction in Hamilton Depression score). Responders showed an increase in daytime activity, phase-advance of the activity-rest rhythm of 57 min compared to the pre-treatment baseline, and reduced nighttime sleep. Non-responders did not show significant changes in the parameters of their activity-rest rhythm. Phase advance of the activity-rest rhythm is an actimetric correlate of the antidepressant response to TSD and LT in bipolar depression. Results are consistent with the known effects of sleep-wake manipulations and neurotransmitter function on the suprachiasmatic nucleus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A total of 3618 related publications were initially retrieved. According to the inclusion and exclusion criteria, 12 were selected after screening [52–63].”
From Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis (2020) · cites this paper as [61]
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Aitken, R. C. B. (1969) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576906201005 · Cited by 1,539
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166
The neural substrates of affective processing in depressed patients treated with venlafaxine
Davidson, R. J., Irwin, W., Anderle, M. J., & Kalin, N. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.64 · Cited by 487 · cited 2×
“, 2001) and neural response to emotional stimuli (Benedetti et al., 2007; Davidson et al., 2003) in the same brain areas.”
BackgroundSleep deprivation in depression: what do we know, where do we go?
Wirz-Justice, A., & Van den Hoofdakker, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00125-0 · Cited by 429
Complex Interaction of the Sleep-Wake Cycle and Circadian Phase Modulates Mood in Healthy Subjects
Boivin, D. B. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140055010 · Cited by 378 · cited 2×
“…by progressive lowering (a pattern opposite to that usually shown by depressed subjects), and components related to the circadian process, with the currently perceived mood being the result of the phase-relationships between the sleep-wake cycle and the circadian system (Boivin et al., 1997).”
BackgroundCircadian Time of Morning Light Administration and Therapeutic Response in Winter Depression
Terman, J. S., Terman, M., Lo, E.-S., & Cooper, T. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.69 · Cited by 366 · cited 2×
“Light is a powerful external zeitgeber, F. Benedetti et al.932 and when given in the morning, it advances the phase of the activity-rest rhythm (see recent review of Schibler, 2006), an effect that in human depressed patients has been related to therapeutic efficacy (Terman et al., 2001).”
BackgroundCirelli, C., & Tononi, G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)03008-0 · Cited by 364 · cited 1×
“…factors, genes related to energy metabolism, growth factors, adhesion molecules, chaperones, and heat shock proteins, vesicle- and synapserelated genes, neurotransmitter and hormone receptors, neurotransmitter transporters, and enzymes, which are enhanced by TSD (Cirelli & Tononi, 2000).”
BackgroundNeurobiological bases for the relation between sleep and depression
Adrien, J. (2002) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(01)90200-x · Cited by 350 · cited 1×
“These effects are thought to be linked with the clinical antidepressant response (Adrien, 2002; Ebert & Berger, 1999).”
BackgroundSleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation.
Borbély, A. A., & Wirz‐Justice, A. (1982) · PubMed · Cited by 323
Sleep states alter activity of suprachiasmatic nucleus neurons
Deboer, T., Vansteensel, M. J., Détári, L., & Meijer, J. H. (2003) · Nature Neuroscience · doi:10.1038/nn1122 · Cited by 323 · cited 1×
“At the level of the “master clock,” sleep states can alter the activity of SCN neurons, with the highest discharge rate during waking and REM sleep and lowest discharge rate during slow wave sleep (Deboer et al., 2003).”
BackgroundActigraphic assessment of circadian activity and sleep patterns in bipolar disorder
Jones, S. H., Hare, D. J., & Evershed, K. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00187.x · Cited by 322 · cited 2×
“…concerning the effects of TSD and LT on biological rhythms in Bipolar Disorder, for which acute response rates of 60–70% have been described (see review of Wirz-Justice et al., 2005) and for which actigraphy has revealed subtle abnormalities even in euthymic conditions (Jones et al., 2005).”
BackgroundDopaminergic Control of Sleep–Wake States
Dzirasa, K., Ribeiro, S., Costa, R., Santos, L. M., Lin, S.-C., Grosmark, A., Sotnikova, T. D., Gainetdinov, R. R., Caron, M. G., & Nicolelis, M. A. L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1767-06.2006 · Cited by 319
Dahan, L., Astier, B., Vautrelle, N., Urbain, N., Kocsis, B., & Chouvet, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301251 · Cited by 294
A role for cryptochromesin sleep regulation
Wisor, J. P., O'Hara, B. F., Terao, A., Selby, C. P., Kilduff, T. S., Sancar, A., Edgar, D. M., & Franken, P. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-20 · Cited by 291 · cited 2×
“In animal models, sleep deprivation can entrain the circadian clock and alter gene expression within the SCN (Antle & Mistlberger, 2000), affect the genetic transcriptional-translational feedback loop of the clock by increasing the expression of per1 and per2 mRNA (Wisor et al., 2002), and causes phase-advance of the…”
BackgroundChronotherapeutics (light and wake therapy) in affective disorders
WIRZ-JUSTICE, A., BENEDETTI, F., BERGER, M., LAM, R. W., MARTINY, K., TERMAN, M., & WU, J. C. (2005) · Psychological Medicine · doi:10.1017/s003329170500437x · Cited by 291 · cited 1×
“…concerning the effects of TSD and LT on biological rhythms in Bipolar Disorder, for which acute response rates of 60–70% have been described (see review of Wirz-Justice et al., 2005) and for which actigraphy has revealed subtle abnormalities even in euthymic conditions (Jones et al., 2005).”
BackgroundSelf-citationKatz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252 · cited 1×
“This is consistent with the wide literature that reports psychomotor retardation, usually being worse in the morning, as one of the first symptoms Phase Advance: A Correlate of Antidepressant Response 933 targeted by antidepressant treatment (e.g., Katz et al., 2004).”
ResultEthics, Standards, and Procedures of Animal and Human Chronobiology Research
Touitou, Y., Smolensky, M. H., & Portaluppi, F. (2006) · Chronobiology International · doi:10.1080/07420520601055308 · Cited by 237 · cited 1×
“The experimental protocol conformed to international ethical standards established for research on human beings (Touitou et al., 2006).”
BackgroundCircadian Clock Resetting by Sleep Deprivation without Exercise in the Syrian Hamster
Antle, M. C., & Mistlberger, R. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09326.2000 · Cited by 227 · cited 5×
“Phase-dependent phase shift of methamphetamine-induced circadian rhythm by haloperidol in SCN-lesioned rats.”
BackgroundInfluentialConti, B., Maier, R., Barr, A. M., Morale, M. C., Lu, X., Sanna, P. P., Bilbe, G., Hoyer, D., & Bartfai, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001897 · Cited by 204 · cited 2×
“Other neurobiological mechanisms could involve the arousal-enhancing transmitter norepinephrine, which is markedly enhanced by TSD (Conti et al., 2007), or the expression of several immediate-early genes and transcription factors, genes related to energy metabolism, growth factors, adhesion molecules, chaperones, and…”
BackgroundCircadian Phase Variation in Bipolar I Disorder
Mansour, H. A., Wood, J., Chowdari, K. V., Dayal, M., Thase, M. E., Kupfer, D. J., Monk, T. H., Devlin, B., & Nimgaonkar, V. L. (2005) · Chronobiology International · doi:10.1081/cbi-200062413 · Cited by 204 · cited 2×
“…role for putative alterations of circadian physiology (see review of Wirz-Justice, 1995), as circadian phase F. Benedetti et al.922 preferences (morningness/eveningness) are correlated with clinical variables (age at onset, duration of illness episodes) in bipolar patients (Mansour et al., 2005).”
BackgroundBenedetti, F., Barbini, B., Fulgosi, M. C., Colombo, C., Dallaspezia, S., Pontiggia, A., & Smeraldi, E. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1207 · Cited by 180 · cited 1×
“In agreement with the literature regarding the efficacy of the combined TSDþ LT in bipolar depression (Benedetti et al., 2005), two-thirds (26/39) of the patients responded to treatment and did not significantly differ from non-responders on any baseline variable.”
ResultSelf-citationGlass, J. D., Grossman, G. H., Farnbauch, L., & DiNardo, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07451.2003 · Cited by 176 · cited 2×
“, 2000), which mediates the non-photic entrainment of the clock (Glass et al., 2003).”
BackgroundBenedetti, F., Serretti, A., Colombo, C., Campori, E., Barbini, B., di Bella, D., & Smeraldi, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1450 · Cited by 167 · cited 4×
“These 5-HT enhancing effects of TSD and LT could also explain the sleep reduction in responders, a phenomenon observed in the present study, because pharmacogenetic studies have showed that human homozygotes for the long variants of the serotonin promoter gene polymorphism, which respond better to both antidepressant…”
BackgroundResultSelf-citationWolff, E. A., Putnam, F. W., & Post, R. M. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260086010 · Cited by 157
Agomelatine: A Preliminary Review of a New Antidepressant
Zupancic, M. J., & Guilleminault, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620120-00003 · Cited by 155 · cited 1×
“The recent reports of phase-advancing effects of antidepressant drugs in rodents (Sprouse et al., 2006) and of antidepressant effects of phase-advancing drugs in humans (Zupancic & Guilleminault, 2006) warrant interest in these issues and for the present preliminary results.”
Uz, T., Ahmed, R., Akhisaroğlu, M., Kürtüncü, M., Imbesi, M., Arslan, A. D., & Manev, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.003 · Cited by 154 · cited 2×
“, 2006) and influences the expression of clock genes (Uz et al., 2005) in the suprachiasmatic nuclei (SCN), thus suggesting continuous cross-talk between monoaminergic neurotransmettitorial systems and the biological clock.”
BackgroundMorning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152 · cited 2×
“…the promoter for the 5-HT transporter influences the antidepressant response to 5-HT reuptake inhibitor medications (Serretti et al., 2005) and to TSD when applied alone (Benedetti et al., 1999) or in combination with LT (Benedetti et al., 2003a) in the same direction and with similar effect sizes.”
BackgroundSelf-citationCircadian rhythms in mammalian neurotransmitter receptors
Wirz‐Justice, A. (1987) · Progress in Neurobiology · doi:10.1016/0301-0082(87)90022-0 · Cited by 140 · cited 2×
“These chronobiological hypotheses are not alternative to neurobiological findings, because brain neurotransmitter function follows a circadian pattern (Martin & Redfern, 1997; Wirz-Justice, 1987) and because in preclinical models, serotonergic antidepressant medication advances the phase of the biological clock (Sprou…”
Neumeister, A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140043008 · Cited by 136 · cited 1×
“For 5-HT, the evidence clearly shows that tryptophan depletion reverses the beneficial effects of LT (Neumeister et al., 1997).”
BackgroundEbert, D., Feistel, H., Kaschka, W. P., Barocka, A., & Pirner, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90024-8 · Cited by 133 · cited 2×
“, 1979), and brain D2 receptor occupancy significantly differed in responders and non-responders, suggesting an enhanced DA release in responders (Ebert et al., 1994).”
BackgroundSerretti, A., Benedetti, F., Zanardi, R., & Smeraldi, E. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.013 · Cited by 132 · cited 1×
“Moreover, a polymorphism in the promoter for the 5-HT transporter influences the antidepressant response to 5-HT reuptake inhibitor medications (Serretti et al., 2005) and to TSD when applied alone (Benedetti et al., 1999) or in combination with LT (Benedetti et al., 2003a) in the same direction…”
BackgroundSelf-citationRaoux, N., Benoit, O., Dantchev, N., Denise, P., Franc, B., Alliale, J.-F., & Widlöcher, D. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90122-8 · Cited by 123 · cited 2×
“…levels after treatment with medications of different classes, including selective serotonin reuptake inhibitor (SSRI), trycyclic, and carbamazepine medications (Joffe et al., 1987; Raoux et al., 1994; Royant-Parola et al., 1986; Stanley et al., 1999; Volkers et al., 2002; Wolff et al., 1985).”
BackgroundResultSprouse, J., Braselton, J., & Reynolds, L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.003 · Cited by 122 · cited 3×
“…1997; Wirz-Justice, 1987) and because in preclinical models, serotonergic antidepressant medication advances the phase of the biological clock (Sprouse et al., 2006) and influences the expression of clock genes (Uz et al., 2005) in the suprachiasmatic nuclei (SCN), thus suggesting continuous…”
BackgroundResultFertl, E., Auff, E., Doppelbauer, A., & Waldhauser, F. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257677 · Cited by 113 · cited 2×
“Moreover, the DA-enhancing effects of TSD could contribute to the observed effects, because DA can entrain the activity-rest rhythm (Fertl et al., 1993; Honma & Honma, 1995), regulate the generation of sleep-wake states (Dzirasa et al., 2007), and exert complex effects on the physiological…”
BackgroundAdjunctive Bright Light in Non‐Seasonal Major Depression
Martiny, K. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00460_2.x · Cited by 105 · cited 2×
“TSD and LT are clinically synergistic with medications that enhance serotonergic (e.g., Benedetti et al., 1997, 2003b; Martiny, 2004), noradrenergic (e.”
BackgroundBenedetti, F., Bernasconi, A., Blasi, V., Cadioli, M., Colombo, C., Falini, A., Lorenzi, C., Radaelli, D., Scotti, G., & Smeraldi, E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.179 · Cited by 101 · cited 1×
“…with this perspective are brain imaging studies that show that both TSD and antidepressant medications cause changes in brain metabolism (Mayberg et al., 2003; Wu et al., 2001) and neural response to emotional stimuli (Benedetti et al., 2007; Davidson et al., 2003) in the same brain areas.”
BackgroundSelf-citationBenedetti, F., Colombo, C., Serretti, A., Lorenzi, C., Pontiggia, A., Barbini, B., & Smeraldi, E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01894-2 · Cited by 100 · cited 2×
“…the promoter for the 5-HT transporter influences the antidepressant response to 5-HT reuptake inhibitor medications (Serretti et al., 2005) and to TSD when applied alone (Benedetti et al., 1999) or in combination with LT (Benedetti et al., 2003a) in the same direction and with similar effect sizes.”
BackgroundSelf-citationWinkler, D., Pjrek, E., Praschak-Rieder, N., Willeit, M., Pezawas, L., Konstantinidis, A., Stastny, J., & Kasper, S. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.031 · Cited by 99 · cited 2×
“…circadian patterns of healthy subjects (Koorengevel et al., 2003), the response to LT is paralleled by marked changes in the activity-rest rhythm (Winkler et al., 2005), such as increased amplitude, increased sleep efficiency, phase advance (earlier acrophase), and stronger coupling between the…”
BackgroundEbert, D., & Berger, T. (1998) · Psychopharmacology · doi:10.1007/s002130050732 · Cited by 99
Sleep deprivation stimulates serotonin release in the suprachiasmatic nucleus
Grossman, G., Mistlberger, R. E., Antle, M. C., Ehlen, J. C., & Glass, J. D. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00024 · Cited by 96
Gardner, J., Fornal, C. A., & Jacobs, B. L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00025-0 · Cited by 90 · cited 2×
“Neurobiological studies show that TSD causes major changes in brain serotonin (5-HT), with an increase in serotonergic activity of the raphe neurons (Gardner et al., 1997), which leads to increased 5-HT turnover in all areas of the brain (Hery et al.”
BackgroundCircadian time keeping: the daily ups and downs of genes, cells, and organisms
Schibler, U. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)53016-x · Cited by 87 · cited 1×
“Light is a powerful external zeitgeber, F. Benedetti et al.932 and when given in the morning, it advances the phase of the activity-rest rhythm (see recent review of Schibler, 2006), an effect that in human depressed patients has been related to therapeutic efficacy (Terman et al., 2001).”
BackgroundHery, F., Pujol, J. F., López, M. D. G., Macon, J. B., & Glowinski, J. (1970) · Brain Research · doi:10.1016/0006-8993(70)90419-1 · Cited by 86 · cited 2×
“, 1997), which leads to increased 5-HT turnover in all areas of the brain (Hery et al., 1970) and increased brain dopamine (DA) with enhanced DA turnover (Zwicker & Calil, 1986).”
BackgroundSleep deprivation hastens the antidepressant action of fluoxetine
Benedetti, F., Barbini, B., Lucca, A., Campori, E., Colombo, C., & Smeraldi, E. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900200 · Cited by 85 · cited 1×
“TSD and LT are clinically synergistic with medications that enhance serotonergic (e.g., Benedetti et al., 1997, 2003b; Martiny, 2004), noradrenergic (e.g., Shelton & Loosen, 1993; Szuba et al., 1994), mixed serotonergic-noradrenergic (e.g., Elsenga & Van den Hoofdakker, 1982, 1983; Kuhs et al.,…”
BackgroundSelf-citationSzuba, M. P., Baxter, L. R., Fairbanks, L. A., Guzé, B. H., & Schwartz, J. M. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90237-g · Cited by 84
Clinical effects of sleep deprivation and clomipramine in endogenous depression
Elsenga, S., & van den Hoofdakker, R. H. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90041-3 · Cited by 77
Kuhs, H., Färber, D., Borgstädt, S., Mrosek, S., & Tölle, R. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00074-7 · Cited by 69 · cited 2×
“, 1994), mixed serotonergic-noradrenergic (e.g., Elsenga & Van den Hoofdakker, 1982, 1983; Kuhs et al., 1996), or dopaminergic (Benedetti et al.”
BackgroundWu, J. C., Buchsbaum, M. S., & Bunney, W. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00336-0 · Cited by 64 · cited 2×
“…with this perspective are brain imaging studies that show that both TSD and antidepressant medications cause changes in brain metabolism (Mayberg et al., 2003; Wu et al., 2001) and neural response to emotional stimuli (Benedetti et al., 2007; Davidson et al., 2003) in the same brain areas.”
BackgroundA clinical trial of sleep deprivation in combination with antidepressant medication
Leibenluft, E., Moul, D. E., Schwartz, P. J., Madden, P. A. F., & Wehr, T. A. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90090-4 · Cited by 57 · cited 3×
“…in the morning a modified version of the 21-item Hamilton Depression Rating Scale (HDRS) fromwhich items that could not bemeaningfully rated due to the TSD procedure and to the time frame were excluded (i.e., weight changes and insomnia, items # 4–6 and 16 on HDRS-NOW; Leibenluft et al., 1993).”
MethodInfluential24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder
Volkers, A. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00019-6 · Cited by 56 · cited 2×
“…levels after treatment with medications of different classes, including selective serotonin reuptake inhibitor (SSRI), trycyclic, and carbamazepine medications (Joffe et al., 1987; Raoux et al., 1994; Royant-Parola et al., 1986; Stanley et al., 1999; Volkers et al., 2002; Wolff et al., 1985).”
BackgroundResultMonitoring of Long-Term Motor Activity in Depressed Patients
Royant‐Parola, S., Borbély, A. A., Tobler, I., Benoit, O., & Widlöcher, D. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.3.288 · Cited by 49 · cited 2×
“…levels after treatment with medications of different classes, including selective serotonin reuptake inhibitor (SSRI), trycyclic, and carbamazepine medications (Joffe et al., 1987; Raoux et al., 1994; Royant-Parola et al., 1986; Stanley et al., 1999; Volkers et al., 2002; Wolff et al., 1985).”
BackgroundResultDopaminergic augmentation of sleep deprivation effects in bipolar depression
Benedetti, F., Campori, E., Barbini, B., Fulgosi, M. C., & Colombo, C. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00332-8 · Cited by 43 · cited 2×
“…2003b; Martiny, 2004), noradrenergic (e.g., Shelton & Loosen, 1993; Szuba et al., 1994), mixed serotonergic-noradrenergic (e.g., Elsenga & Van den Hoofdakker, 1982, 1983; Kuhs et al., 1996), or dopaminergic (Benedetti et al., 2001) neurotransmission, thus suggesting shared mechanisms of action.”
BackgroundSelf-citationKoorengevel, K. M., Beersma, D. G. M., den Boer, J. A., & van den Hoofdakker, R. H. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(02)00305-0 · Cited by 42 · cited 1×
“Available data focused on Seasonal Affective Disorder (SAD) has showed that though mood follows the same circadian patterns of healthy subjects (Koorengevel et al., 2003), the response to LT is paralleled by marked changes in the activity-rest rhythm (Winkler et al., 2005), such as increased…”
BackgroundSleep deprivation accelerates the response to nortriptyline
Shelton, R. C., & Loosen, P. T. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90036-r · Cited by 38 · cited 1×
“…LT are clinically synergistic with medications that enhance serotonergic (e.g., Benedetti et al., 1997, 2003b; Martiny, 2004), noradrenergic (e.g., Shelton & Loosen, 1993; Szuba et al., 1994), mixed serotonergic-noradrenergic (e.g., Elsenga & Van den Hoofdakker, 1982, 1983; Kuhs et al., 1996), or…”
BackgroundThe effects of REM sleep deprivation on striatal dopamine receptor sites
Zwicker, A. P., & Calil, H. M. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90415-6 · Cited by 35 · cited 1×
“…major changes in brain serotonin (5-HT), with an increase in serotonergic activity of the raphe neurons (Gardner et al., 1997), which leads to increased 5-HT turnover in all areas of the brain (Hery et al., 1970) and increased brain dopamine (DA) with enhanced DA turnover (Zwicker & Calil, 1986).”
BackgroundPutzhammer, A., Schoeler, A., Rohrmeier, T., Sand, P. G., Hajak, G., & Eichhammer, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1995-3 · Cited by 31 · cited 3×
“, 1999), also reduce their sleep and increase their nighttime locomotor activity when treated with SSRIs (Putzhammer et al., 2005).”
BackgroundMotor activity in depressed patients treated with carbamazepine
Joffe, R. T., Uhde, T. W., Post, R. M., & Minichiello, M. D. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90003-5 · Cited by 30 · cited 2×
“…levels after treatment with medications of different classes, including selective serotonin reuptake inhibitor (SSRI), trycyclic, and carbamazepine medications (Joffe et al., 1987; Raoux et al., 1994; Royant-Parola et al., 1986; Stanley et al., 1999; Volkers et al., 2002; Wolff et al., 1985).”
BackgroundResultHonma, S., & Honma, K.-I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00027-n · Cited by 29 · cited 1×
“…the DA-enhancing effects of TSD could contribute to the observed effects, because DA can entrain the activity-rest rhythm (Fertl et al., 1993; Honma & Honma, 1995), regulate the generation of sleep-wake states (Dzirasa et al., 2007), and exert complex effects on the physiological functions…”
BackgroundEffects of Fluoxetine and Dothiepin on 24-Hour Activity in Depressed Patients
Stanley, N., Fairweather, D. B., & Hindmarch, I. (1999) · Neuropsychobiology · doi:10.1159/000026559 · Cited by 25 · cited 2×
“…levels after treatment with medications of different classes, including selective serotonin reuptake inhibitor (SSRI), trycyclic, and carbamazepine medications (Joffe et al., 1987; Raoux et al., 1994; Royant-Parola et al., 1986; Stanley et al., 1999; Volkers et al., 2002; Wolff et al., 1985).”
BackgroundResultLormetazepam in depressive insomnia: new evidence of phase-response effects of benzodiazepines
Benedetti, F., Pontiggia, A., Bernasconi, A., Colombo, C., Florita, M., & Smeraldi, E. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000132776.05964.01 · Cited by 20 · cited 1×
“In agreement with the existing literature about insomnia in mood disorders (Benedetti et al., 2004), sleep onset was inversely correlated with night sleep, irrespective of treatment response status.”
BackgroundSelf-citationPolysomnography and criteria for the antidepressant response to sleep deprivation
Clark, C. P., & Golshan, S. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.020 · Cited by 13 · cited 1×
“The response criterion was a 50% reduction in HDRS scores on day 7 (Clark & Golshan, 2007).”
BackgroundMartin, K. F., & Redfern, P. H. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09355-9_7 · Cited by 11 · cited 1×
“…chronobiological hypotheses are not alternative to neurobiological findings, because brain neurotransmitter function follows a circadian pattern (Martin & Redfern, 1997; Wirz-Justice, 1987) and because in preclinical models, serotonergic antidepressant medication advances the phase of the…”
BackgroundSocial functioning and quality of life of patients with first episode schizophrenia
Górna, K., Suwalska, A., Jaracz, K., & RYBAKOWSKI, J. K. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80372-8 · Cited by 1
Research works printed but not linked: 3
- Aitken R CB, 1969, Proc. R. Soc. Med., 62, 989
- Borbely A A, 1982, Human Neurobiol., 1, 205
- Wehr T A, 1980, Sleep, 26
Cited by
Sleep disorders as core symptoms of depression
Nutt, D., Wilson, S., & Paterson, L. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/dnutt · Cited by 839
“Further evidence is gained from studies showing that those patients who respond to sleep deprivation and to light treatment are those in whom phase advance has been demonstrated by actimetry (a technique which measures sleep-wake cycles using movement sensors worn for many weeks on the wrist).(30) There is evidence fr…”
BackgroundTrull, T. J., & Ebner-Priemer, U. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185510 · Cited by 761
Ethical and Methodological Standards for Laboratory and Medical Biological Rhythm Research
Portaluppi, F., Touitou, Y., & Smolensky, M. H. (2008) · Chronobiology International · doi:10.1080/07420520802544530 · Cited by 326
“non-depression (Benedetti et al., 2007), and diabetes/metabolic syndrome vs.”
BackgroundSleep and circadian functioning: critical mechanisms in the mood disorders?
Harvey, A. G. (2011) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032210-104550 · Cited by 237
“The results are promising (Benedetti et al. 2001, 2007).”
BackgroundMatveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Metadata
- Authors
- Benedetti, F., Dallaspezia, S., Fulgosi, M. C., Barbini, B., Colombo, C., & Smeraldi, E.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Benedetti, Francesco
- Venue
- Chronobiology International
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 24
- Issue
- 5
- Pages
- 921-937
- ISSN
- 0742-0528 (ISSN-L)
- 1525-6073
- OpenAlex
- W2056765607
- Cited by
- 97
- References
- 64
- Citations by year
- 2026: 2 · 2024: 2 · 2022: 3 · 2021: 8 · 2020: 10 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 6 · 2013: 5 · 2012: 6
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chronobiology International (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar depression, total sleep deprivation, phototherapy, phase advance, actigraphy, biological rhythms, antidepressant response, suprachiasmatic nucleus, monoaminergic systems, circadian rhythm
- MeSH terms
- Activity Cycles, Adult, Antidepressive Agents, Bipolar Disorder, Circadian Rhythm, Female, Humans, Male, Middle Aged, Phototherapy, Sleep Deprivation, Chronotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.